Title:
がん治療における抗ＥｐＣＡＭ抗体の使用
Document Type and Number:
Japanese Patent JP2023514470
Kind Code:
A
Abstract:
本開示は、抗EpCAM抗体の治療的使用に関する。また、抗EpCAM抗体及びPD-L1免疫チェックポイント阻害剤の併用免疫療法が提供される。【選択図】図７
More Like This:
| JP2023162213 | INHIBITOR OF SUV39H1 HISTONE METHYLTRANSFERASE FOR USE IN CANCER COMBINATION THERAPY |
| WO/1997/033619 | IMPROVED VISION THROUGH PHOTODYNAMIC THERAPY OF THE EYE |
| WO/1997/046688 | LIPID KINASE |
Inventors:
Woo, Han-Chun
Chen, Hao-Nien
Chen, Hao-Nien
Application Number:
JP2022527232A
Publication Date:
April 06, 2023
Filing Date:
November 16, 2020
Export Citation:
Assignee:
ACADEMIA SINICA
International Classes:
A61K45/00; A61K31/7088; A61K31/7105; A61K31/713; A61K39/395; A61K45/08; A61K48/00; A61P35/00; A61P35/04; C07K16/28
Attorney, Agent or Firm:
Patent Attorney Corporation Hiraki International Patent Office
Previous Patent: Inter-prediction method, encoder, decoder, and storage medium
Next Patent: motion-based media creation
Next Patent: motion-based media creation